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aimed at providing patients with more knowledge. Armed 
with insight, personal behaviour patterns which influence 
treatment outcomes can be challenged. Our belief is that a 
well informed patient will be less anxious and insecure. The 
information that we give is to repress misconception, reduce 
unrealistic fears and provide predicitive information. The 
latter is to let the patient know what we do during the 
ratiation and why, further to inform the patient what side 
effects the patient can develop after an period of time. We 
try to support the patient in different areas. We try to meet 
within the needs in the pyramid of Maslow. It states that a 
human being among other things is in need of safety and 
security, need for social contact and is in need of 
appreciation and recognition. In the conversation we try to 
acknowledge their fears and and recognize that these may 
exist and by giving information we try to repress those fears. 
We try as much as possible to be really in contact with the 
patient and to connect whith the experiences of the patient. 
To reassure them and to let them know what we do and why, 
we try let them feel safer and more certain about the 
process they will be going through. To give the patient also 
some sense of control over the radiation we hope to achieve 
that the patient feels he/she also affects the process and 
thus have the situation more under control. The information 
is given with use of an PowerPoint presentation with supports 
the story the radiation technician is giving. In this 
presentation he shows pictures that support the story. The 
radiation technician uses the knowledge that a person 
remembers 20% of what they read, 35% of what they see and 
55% when you combine these two.  
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Purpose or Objective: Stress influences our communication: 
the way how we interpret the world, our communications 
style we use to interact with our environment and our 
internal communication. During the presentation, 
neuropsychological insights into communication will be 
presented. These insights will be used to introduce some 
pragmatic intervention to monitor and control 
communication. 
 
Materials and Methods: a literature review of the impact of 
stress on our information processing system and hence, our 
communication and of possible intervention that can 
positively influence our information processing 
 
Results: Several brain mechanisms can negatively influence 
our communication. Our knowledge of these mechanisms is 
key in understanding and identifying possible communication 
styles. In cancer, we see many patients and their relatives 
struggling with the information-processing. Coping strategies 
like avoiding and neglect, for instance, are effective in the 
short-term but in the long run, flexibility in coping is 
required to ensure shared decision making in cancer care. 
Indeed, shared decision making is the priority in cancer care. 
Caregivers, specialists and the patients collaborate ensure 
the best possible cancer care. Shared decision making 
requires an efficient information processing. However, stress 
has a strong impact on this shared decision making process. 
Results from cognitive behavioral interventions and 
intervention based on positive psychology positively influence 
information processing and stress-levels. Including these 
strategies can facilitate emotion regulation and hence, 
shared decision making in cancer care. 
 
Conclusion: Stress negatively impact our information 
processing and hence, our communication. On the other 
hand, communication is the central factor in shared decision 
making. Caregivers, specialists and patients should always be 
aware of these possible disruptive factor in order to ensure 
shared decision making in cancer care. 
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Successful implementation of functional imaging in radiation 
therapy requires understanding of images. This includes 
radiobiological interpretation, quantification as well as 
validation of the prognostic and predicitve value. This talk 
will reflect on functional imaging and its link to 
radiobiological mechanisms of radiation response and discuss 
current knowledge as well as ongoing research in image 
validation. 
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Medical imaging has a fundamental role in radiotherapy 
planning today, but is almost exclusively used for assessing 
anatomical features like tumor size, stage and spreading. 
Introduction of functional imaging provides an opportunity to 
also consider biological features of disease aggressiveness in 
the clinical decision making. Recent advances in genomic 
research have led to promising molecular biomarkers of 
treatment outcome, but it is not clear how to best translate 
them into clinical practice and face challenges related to 
tissue sampling and intratumor heterogeneity. 
Radiogenomics, which refer to extraction of image features 
reflecting cancer genomics, allow visualization of molecular 
biomarkers within the entire tumor and have been proposed 
as a promising tool for this purpose. Such analyses provide a 
better understanding of the molecular background of the 
images and open for the use of imaging in the planning of 
combination therapies with radiation. In this talk, I will 
present clinical data on associations between functional MR 
imaging and biopsy based genomic biomarkers and reflect on 
the challenge of intratumor heterogeneity for such 
investigations. I will further discuss the potential of 
combining functional MR imaging and genomic signatures in 
the prediction of radiotherapy outcome. Examples will be 
given from published data and from our ongoing studies on 
cervical cancer and prostate cancer.  
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Molecular imaging adds value in each of the steps of the 
radiotherapy process: (1) Diagnosis and staging, (2) Target 
definition, and (3) Treatment response assessment. As such, 
it remains an important tool for optimization of radiation 
therapy. At the moment there is no general consensus how 
molecular imaging should be utilized in defining treatment 
target. A number of automatic and semi-automatic 
approaches exist, but their use in treatment planning is 
limited. Dose painting – biologically conformal radiotherapy – 
is an exciting concept, but still needs further development. 
Its feasibility has been established in various tumor types, 
and early efficacy clinical trials are underway. Generally, 
post-RT molecular imaging, particularly FDG PET/CT has a 
high negative predictive value (NPV), but rather 
low/moderate positive predictive value (PPV) for predicting 
treatment outcome. Early RT molecular imaging response 
assessment is promising and provides potential for innovative 
adaptive approaches. High inter- and intra-tumor response 
heterogeneity remains challenging. 
 
 
 
